Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin
Evelyn Krohmer, Brit Silja Rohr, Felicitas Stoll, Katja S Gumus, Mariano Bergamino, Gerd Mikus, Max Sauter, Jurgen Burhenne, Johanna Weiss, Andreas D. Meid, David Czock, Antje Blank, Walter E Haefeli
Post-doctoral researcher in Clinical Pharmacology & Pharmacoepidemiology
My research interests include the study of appropriate drug therapy using methods of pharmacoepidemiology, quantitative pharmacology, and pharmacometrics.